Esperion Therapeutics

Developer of lipoprotein cholesterol (LDL-C) lowering therapies

placeAnn Arbor, Michigan, United States calendar_todayFounded 1998 groups240 employees language esperion.com

Registered entities

Social engagement

Social engagement: 24.3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

18 investors on record; lead investors include TL Ventures, Healthcap, Canaan, Avalon Investment Services; 2 have since exited.

Investor typeCountShare
Venture capital1267%
Private equity528%
Other / undisclosed16%

Hiring activity

Hires periodically

3 roles tracked across 3 of the last 12 months

19 May 2026 · Territory Manager, Sales · Palm Bay

20 Sep 2025 · Associate Director/Director of Medical Engagement · Ann Arbor

11 Sep 2025 · Regulatory Ops: Senior Associate or Manager · Ann Arbor

31 May 2025 · Manager, Gross Margin Accounting · Ann Arbor

11 Nov 2024 · Sr Dir, Digital Strategy & BPO · Ann Arbor

Based on job postings tracked across public sources.

Recent activity

29 Jun 2026
Product launch
ACC Lipid Manager app
Coming soon